Patent Law Weblog
recent posts
- Reasons for the PTAB’s Priority Determination in Broad’s Favor (Perhaps)
- Mexico Publishes Amendments to Intellectual Property Law
- PTAB (Again) Awards Priority of Invention to Broad in Interference No. 106,115
- Argentina Repeals Pharmaceutical Patent Examination Guidelines
- USPTO Moves to Protect Design Rights for Digital Innovations
about
Category: District Court
-
By Donald Zuhn — It is natural at this time of year to reflect upon the events of the past twelve months in the hope that such a review might provide some indication of what to expect in the coming year. In order to help focus on possible developments in biotech and pharma…
-
Judge James C. Cacheris of the Eastern District of Virginia has issued his Order, Memorandum and Opinion, and Minute entry for proceedings following today’s hearing in the consolidated cases of SmithKline Beecham Corp. v. Dudas and Tafas v. Dudas. Patent Docs will provide additional coverage of the Court’s Order and Opinion later today.
-
By Kevin E. Noonan — On October 9th, SmithKline Beecham Corp., SmithKline Beecham PLC, and Glaxo Group Ltd. (d/b/a/ collectively as GlaxoSmithKline) filed a verified complaint in the U.S. District Court for the Eastern District of Virginia against John Dudas and the U.S. Patent and Trademark Office, asking for preliminary and permanent injunctions…
-
Eli Lilly & Co. v. Emisphere Techs., Inc., No. 03-cv-1504-DFH (S.D. Ind.) By Robert Dailey — This week Eli Lilly agreed to pay $18 million to settle its contract and patent dispute with biotech start-up Emisphere. In the late 90s, the two companies had agreed to work together to develop an oral delivery…
-
Tafas v. Dudas, No. 07-CV-846 (E.D. Va.) (filed Aug. 22, 2007) By Robert Dailey — Triantafyllos Tafas has amended his complaint challenging the new USPTO rules set to take effect November 1, 2007. In addition, Tafas has withdrawn his motion for a preliminary injunction (PI) enjoining the PTO from implementing the new rules. …
-
Tafas v. Dudas, No. 07CV846 (E.D. Va.) (filed Aug. 22, 2007) By Robert Dailey — Dr. Triantafyllos Tafas, a Connecticut inventor, has asked a Federal District Court to prevent the PTO’s new continuation rules from taking effect. Tafas is the named inventor on 18 pending patent applications, and asserts that he will suffer…
-
Aventis Prevails over Impax in Riluzole Dispute By Robert Dailey — On remand from the Federal Circuit (see "Impax Labs., Inc. v. Aventis Pharm. Inc. (Fed. Cir. 2006)"), the District Court found that U.S. Pat. No. 5,527,814 is not anticipated by the prior art. Particularly, the Court found that the anticipating reference cited…
-
Pfizer Earns One More Victory in Norvasc Litigation By Robert Dailey — This week Pfizer won another courtroom battle against generic drug manufacturer Synthon in the companies' ongoing dispute over Pfizer's drug Norvasc. The District Court held two Synthon patents, U.S. Patent Nos. 6,653,481 and 6,858,738 unenforceable due to inequitable conduct. Pfizer had…
-
By Mark Chael — An intellectual property lawsuit is slated to begin on March 12, 2007, pitting Genzyme Corp. against three executives at a Canadian firm, Cytochroma, which is developing therapies for vitamin D deficiency and chronic kidney disease (CKD). Genzyme alleges that the executives misappropriated trade secrets and other intellectual property prior…
-
Innogenetics Appeals Its Win over Abbott By Robert Dailey — In two earlier posts (January 8 and January 12), we reported on Innogenetics' $7 million victory after a jury found that Abbott had infringed Innogenetics' patent covering methods for HCV genotyping. The jury also found that Abbott's conduct had been willful. However, in a…
Patent Docs 